Loading clinical trials...

A Study of Invasive Hemodynamic for MACHD Registry | Clinical Trials | Clareo Health

RECRUITING

A Study of Invasive Hemodynamic for MACHD Registry

Invasive Hemodynamic Control Cohort for The Mayo Clinic Adult Congenital Heart Disease (MACHD) Registry

NCT05849025•Mayo Clinic

Summary

This research study is being done to provide comparative data to the Mayo Clinic Adult Congenital Heart Disease Registry.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Capacity to Consent
•BMI \</= 30
•Systolic BP \</= 140mmHg
•Diastolic BP \</= 90
•eGFR \> 30 (within prior 3 months) to confirm kidney function
•Able to undergo an MRI

Exclusion Criteria

•History of Cardiovascular disease that may affect the results of the testing performed.
•Any Current orthopedic limitations
•Currently taking any cardiac medication
•Pregnancy

Locations (1)

Mayo Clinic Rochester

Rochester, Minnesota, United States

Key Dates

Start Date

October 16, 2023

Primary Completion Date

March 1, 2026

Completion Date

March 1, 2026

Last Updated

January 26, 2026

Enrollment

ESTIMATED participants

Conditions

HealthyCongenital Heart Disease

Contacts

ACHD Research Program

CONTACT

(507) 293-2565

Alexander Egbe, MBBS, MPH

CONTACT

(507) 284-2520 Egbe.Alexander@mayo.edu

A New Portable Device for Non-invasive Ventilatory Support

NCT06716502

HealthyRespiratory Disease

View study

RECRUITING

Collection of Data and Samples From Healthy Donors for Use in Translational Research

NCT00090662

Healthy Volunteer

View study

RECRUITINGPHASE1

Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 26, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Study of Invasive Hemodynamic for MACHD Registry

Inclusion Criteria

Exclusion Criteria

A New Portable Device for Non-invasive Ventilatory Support

Collection of Data and Samples From Healthy Donors for Use in Translational Research

Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease

Fecal Microbiota Transplantation for Patients With Autism Spectrum Disorder.

Turkish Validity and Reliability Study of PRevention of Toxic Chemicals in the Environment for Children Tool

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases